Lawrence C. Newman, MD, is a clinical professor of neurology at the NYU Langone School of Medicine and the director of the Division of Headache at NYU Langone Medical Center.
Before joining NYU, he was the director of the Headache Institute at Mount Sinai Roosevelt Hospital Center in New York City from 1998 until 2016.
Newman completed his neurology residency and chief residency at the Albert Einstein College of Medicine in the Bronx, NY. He did his fellowship in headache medicine at the Montefiore Headache Center in the Bronx as well.
He is a Fellow of the American Academy of Neurology and the American Headache Society. He is also the immediate past president of the American Headache Society.
Newman has consulted for these companies:
- Alder Biopharmaceuticals
- Eli Lilly and Company
- Teva Pharmaceutical Industrics, Ltd.
- Depomed, Inc.
- eNeura Therapeutics
- Zogenix, Inc.